Skip to main content

Table 4 Cost-effectiveness of systematic CRT-D optimization versus optimal pharmacological therapy (OPT) from the perspective of the healthcare payer

From: Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation

 

ICER at 5 yearsa

ICER at 5 yearsa

Difference

 

Systematic CRT-D optimization vs. OPT

Standard CRT-D optimization vs. OPT

Systematic vs. Standard

Country

   

Germany

€ 16,359

€ 22,327

-27 %

France

€ 16,052

€ 23,019

-30 %

Spain

€ 24,440

€ 34,936

-30 %

Italy

€ 15,077

€ 20,738

-27 %

UK

£ 14,950

£ 20,861

-28 %

  1. aICERs are expressed as cost per QALY gained